Theranostic agents represent a recently introduced class of imaging probes designed to
offer to pharmacologists and physicians a robust tool for minimally invasive in vivo …

Nanomedicine formulations aim to improve the biodistribution and the target site
accumulation of systemically applied (chemo-) therapeutics. Various different passively and …

Nanomedicine formulations are considered to be superior to standard low-molecular-weight
drugs because of an increased drug accumulation at the pathological site and a decreased …

Advances in nanotechnology and chemical engineering have led to the development of
many different drug delivery systems. These 1–100 (0)-nm-sized carrier materials aim to …

Nanoparticle technologies are significantly impacting the development of both therapeutic
and diagnostic agents. At the intersection between treatment and diagnosis, interest has …

Introduction: Recent advances in nanoparticle synthesis engineering have made it possible
to combine disease diagnosis and therapy. This progress could help to open the door to …

For decades, researchers and medical professionals have aspired to develop mechanisms
for noninvasive treatment and monitoring of pathological conditions within the human body …

Nanomedicine formulations aim to improve the biodistribution and the target site
accumulation of systemically administered (chemo) therapeutic agents. Many different types …

The concept of personalized medicine has recently emerged as a promising way to address
unmet medical needs. Due to the limitations of standard diagnostic and therapeutic …

This special issue of Molecular Pharmaceutics is dedicated to the topic of theranostics
where we discuss the role of functional nanometer-sized agents in personalized medicine …